Apotex Pharmachem Inc. · 66-66 · CANADA
For Apotex Pharmachem Inc., import alert is 66-66; country is CANADA; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Fluvoxamine Maleate | Buspirone HCl; product code is 61 N - S 67 Fluvoxamine Maleate (Anti-Depressant), Active Pharm Ingred/Chems for Further Manuf | 66 M - S 09 Buspirone HCl (Tranquilizer), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 34 Spalding Dr , Brantford, Ontario CANADA, verified against its source on 2026-09-30.
- Firm
- Apotex Pharmachem Inc. verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- CANADA verified
- Address
- 34 Spalding Dr , Brantford, Ontario CANADA verified
- Date published
- 09/30/2009 verified
- Product code
- 61 N - S 67 Fluvoxamine Maleate (Anti-Depressant), Active Pharm Ingred/Chems for Further Manuf | 66 M - S 09 Buspirone HCl (Tranquilizer), Active Pharm Ingred/Chems for Further Manuf each item verified
- Product
- Fluvoxamine Maleate | Buspirone HCl each item verified
- FDA notes
- 11/2/2000 | 11/2/2000 each item verified
What the source says
Apotex Pharmachem Inc. Date Published : 09/30/2009 34 Spalding Dr , Brantford, Ontario CANADA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
61 N - S 67 Fluvoxamine Maleate (Anti-Depressant), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/20/2019 Desc: Fluvoxamine Maleate Notes: 11/2/2000 66 M - S 09 Buspirone HCl (Tranquilizer), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/20/2019 Desc: Buspirone HCl Notes: 11/2/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html